Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.

Abnormal phosphorylation of tau, one of the most common symptoms of dementia, has become increasingly important in the study of the etiology and development of Alzheimer's disease. Paeoniflorin, the main bioactive component of herbaceous peony, is a monoterpene glycoside, which has been reported to exert beneficial effects on neurodegenerative disease. However, the effect of paeoniflorin on tauopathies remains ambiguous. SH-SY5Y cells were treated with okadaic acid (OA) for 8 h to induce tau phosphorylation and no cell death was observed. Optical microscopy results showed that paeoniflorin ameliorated okadaic acid induced morphological changes, including cell swelling and synapsis shortening. Western blotting data illustrated that paeoniflorin reversed okadaic acid induced tau hyperphosphorylation, which was enhanced by inhibiting the activities of calpain, Akt and GSK-3β. Transmission electron microscopy results showed that paeoniflorin alone can reduce the number of autophagosomes and stabilize the microtubule structure. In addition, calpastain and paeoniflorin enhance the effect of paeoniflorin on stabilizing microtubules. In addition, calpastain markedly enhanced the effect of paeoniflorin on reversing okadaic acid-lowered fluorescence intensity of both MAP-2 and β III-tubulin, two microtubule-associated proteins. This study shows that paeoniflorin protected SH-SY5Y cells against okadaic acid assault by interfering with the calpain/Akt/GSK-3β-related pathways, in which autophagy might be involved. Besides, paeoniflorin is found to relieve the stress response of the microtubule structure system caused by okadaic acid treatment. The results presented in this study suggest that paeoniflorin potentially plays an important role in tauopathies.

• Publication year

  2018

• Venue

  Brain Research

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainres.2018.03.022PMID 29596798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction

  2017cited by this paper
• Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease

  2017cited by this paper
• Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer's disease

  2017cited by this paper
• Review Article Molecular mechanism of prion-like tau-induced neurodegeneration

  2016cited by this paper
• Calpain research for drug discovery: challenges and potential

  2016cited by this paper
• Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate

  2016cited by this paper
• Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2.

  2016cited by this paper
• Tau: From research to clinical development

  2016cited by this paper
• Effect of paeoniflorin on the calcium ion concentration in salivary gland cells using confocal laser scanning microscopy.

  2016cited by this paper
• Synergistic protective effect of paeoniflorin and β-ecdysterone against rotenone-induced neurotoxicity in PC12 cells

  2016cited by this paper
• Paeoniflorin attenuates hepatic ischemia/reperfusion injury via anti-oxidative, anti-inflammatory and anti-apoptotic pathways.

  2016cited by this paper
• Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice

  2016cited by this paper
• 2016 Alzheimer's disease facts and figures

  2016cited by this paper
• Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

  2016cited by this paper
• Paeoniflorin protects diabetic mice against myocardial ischemic injury via the transient receptor potential vanilloid 1/calcitonin gene-related peptide pathway

  2016cited by this paper
• Paeoniflorin, a Monoterpene Glycoside, Protects the Brain from Cerebral Ischemic Injury via Inhibition of Apoptosis.

  2015cited by this paper
• Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.

  2015cited by this paper
• Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I

  2015cited by this paper
• Paeoniflorin diminishes ConA-induced IL-8 production in primary human hepatic sinusoidal endothelial cells in the involvement of ERK1/2 and Akt phosphorylation.

  2015cited by this paper
• Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer’s Disease

  2015cited by this paper
• Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells

  2015cited by this paper
• Calpain-mediated cleavage of DARPP-32 in Alzheimer’s disease

  2015cited by this paper
• Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease

  2015cited by this paper
• Paeoniflorin attenuates Aβ1-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-κB- and VEGF/Flt-1 signaling pathways.

  2015cited by this paper
• Tau in physiology and pathology

  2015cited by this paper
• Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.

  2014cited by this paper
• Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application

  2014cited by this paper
• Alzheimer disease therapy—moving from amyloid-β to tau

  2013cited by this paper
• Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology.

  2013cited by this paper
• Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.

  2013cited by this paper
• Regulatory innovation and drug development for early-stage Alzheimer's disease.

  2013cited by this paper
• Neuroprotective Effects of Paeoniflorin, But Not the Isomer Albiflorin, are Associated with the Suppression of Intracellular Calcium and Calcium/Calmodulin Protein Kinase II in PC12 Cells

  2013cited by this paper
• Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.

  2013cited by this paper
• Tau protein phosphatases in Alzheimer's disease: the leading role of PP2A.

  2013cited by this paper
• Phosphatidylinositol 3 kinase/protein kinase B is responsible for the protection of paeoniflorin upon H₂O₂-induced neural progenitor cell injury.

  2013cited by this paper
• Alzheimer mechanisms and therapeutic strategies.

  2012cited by this paper
• Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

  2012cited by this paper
• Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.

  2011cited by this paper
• Methods in mammalian autophagy research.

  2010cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

  2010cited by this paper
• Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1γ

  2007cited by this paper
• Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

  2007cited by this paper
• The MAP1 family of microtubule-associated proteins

  2006cited by this paper
• Lysosomal Turnover, but Not a Cellular Level, of Endogenous LC3 is a Marker for Autophagy

  2005cited by this paper
• Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes

  2004cited by this paper
• The MAP2/Tau family of microtubule-associated proteins

  2004cited by this paper
• The calpain system.

  2003cited by this paper
• A Regulatory Role for p38δ MAPK in Keratinocyte Differentiation

  2003cited by this paper
• A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation.

  2003cited by this paper
• The GSK3β signaling cascade and neurodegenerative disease

  2002cited by this paper
• PKB binding proteins. Getting in on the Akt.

  2002cited by this paper
• The GSK3 beta signaling cascade and neurodegenerative disease.

  2002cited by this paper
• Cumulative inactivation of the outward potassium current: a likely mechanism underlying electrical memory in human atrial myocytes.

  2001cited by this paper
• Structural insights into microtubule function.

  2000cited by this paper
• Autolysis parallels activation of mu-calpain.

  1996cited by this paper
• Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau

  1995cited by this paper
• Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.

  1995cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a

  1994cited by this paper
• Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

  1993cited by this paper
• Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments

  1993cited by this paper
• Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments.

  1993cited by this paper
• The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis.

  1990cited by this paper
• Okadaic acid: a new probe for the study of cellular regulation.

  1990cited by this paper
• Protein phosphatases: key players in the regulation of cell function.

  1990cited by this paper

• Investigating the Role of Buzhong Yiqi Decoction on Neurogenic Bladder with Network Pharmacology, Molecular Docking, and In Vitro Assays

  2025cites this paper
• The neuroprotective effects and related mechanisms of paeoniflorin on nervous system diseases: a review

  2025cites this paper
• Sea Squirt-Derived Peptide WLP Mitigates OKA-Induced Alzheimer’s Disease-like Phenotypes in Human Cerebral Organoid

  2025cites this paper
• Traditional Chinese Medicine-derived formulations and extracts modulating the PI3K/AKT pathway in Alzheimer’s disease

  2025cites this paper
• Molecular mechanisms of GDNF/GFRA1/RET and PI3K/AKT/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders.

  2025cites this paper
• Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action.

  2024cites this paper
• GSK3: A potential target and pending issues for treatment of Alzheimer's disease

  2024cites this paper
• Therapeutic Potential of Traditional Oriental Medicines in Targeting Tau Pathology: Insights from Cell-free and Cell-based Screening

  2024cites this paper
• A network pharmacology approach to reveal the key ingredients in Scrophulariae Radix (SR) and their effects against Alzheimer's disease

  2024cites this paper
• Ethnobotanical significance of medicinal plants: Beta‐amyloid and tau aggregation inhibitors against Alzheimer's disease

  2023cites this paper
• Identification of Uncaria rhynchophylla in the Potential Treatment of Alzheimer’s Disease by Integrating Virtual Screening and In Vitro Validation

  2023cites this paper
• Discovery of drug lead compounds for Anti-Alzheimer's disease on the basis of synaptic plasticity

  2023cites this paper
• β-asarone Protects p-tau from Okadaic Acid in PC12 Cells by Activating PP2A and Involving Akt/mTOR/Beclin-1 Pathway

  2023cites this paper
• Current Trends in Natural Products for the Treatment and Management of Dementia: Computational to Clinical Studies.

  2023cites this paper
• Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells

  2022cites this paper
• “Drug‐Carrier” Synergy Therapy for Amyloid‐β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly

  2022cites this paper
• Multiple Roles of Paeoniflorin in Alzheimer's Disease

  2022influential citation
• Paeoniflorin Ameliorates BiPN by Reducing IL6 Levels and Regulating PARKIN-Mediated Mitochondrial Autophagy

  2022cites this paper
• A review for the pharmacological effects of paeoniflorin in the nervous system

  2022influential citation
• Yuan-Zhi decoction in the treatment of Alzheimer’s disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation

  2022cites this paper
• Tubulin Cytoskeleton in Neurodegenerative Diseases–not Only Primary Tubulinopathies

  2022cites this paper
• Modulation of circadian clock by crude drug extracts used in Japanese Kampo medicine

  2021cites this paper
• Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases

  2021cites this paper
• Paeoniflorin ameliorates ischemic injury in rat brain via inhibiting cytochrome c/caspase3/HDAC4 pathway

  2021cites this paper
• Research Progress on Natural Product Ingredients' Therapeutic Effects on Parkinson's Disease by Regulating Autophagy

  2021cites this paper
• Dysfunction of the SNARE complex in neurological and psychiatric disorders.

  2021cites this paper
• Autophagy and apoptosis cascade: which is more prominent in neuronal death?

  2021cites this paper
• Self-Assembling Peptide Scaffold Carrying Neural-Cell Adhesion Molecule-Derived Mimetic-Peptide Transplantation Promotes Proliferation and Stimulates Neurite Extension by Modulating Tau Phosphorylation and Calpain/Glycogen Synthase Kinase 3 beta (GSK-3β) in Neurons

  2020cites this paper
• Total glucosides of paeony: A review of its phytochemistry, role in autoimmune diseases, and mechanisms of action.

  2020cites this paper
• Advanced analytical methodologies in Alzheimer's disease drug discovery.

  2020cites this paper
• Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review.

  2020cites this paper
• Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson’s Disease

  2020cites this paper
• Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway

  2020cites this paper
• The melanogenic effects and underlying mechanism of paeoniflorin in human melanocytes and vitiligo mice.

  2019cites this paper
• Paeoniflorin Inhibits Mesangial Cell Proliferation and Inflammatory Response in Rats With Mesangial Proliferative Glomerulonephritis Through PI3K/AKT/GSK-3β Pathway

  2019cites this paper
• A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer's Disease

  2019cites this paper
• Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy.

  2019cites this paper
• Progress in interventional mechanism of paeoniflorin on Alzheimer ’ s disease

  2019cites this paper